Conflict of interest statement: CONFLICTS OF INTEREST S.W. Blain has ownershipinterest (including patents) in Concarlo Holdings, LLC and is aconsultant/advisory board member for Concarlo Holdings, LLC.195. Oncoscience. 2018 Jun 23;5(5-6):120-121. doi: 10.18632/oncoscience.414.eCollection 2018 May.Targeting MYC for triple-negative breast cancer treatment.Klauber-DeMore N(1), Schulte BA(1), Wang GY(1).Author information: (1)Developmental Cancer Therapeutics (DCT) Program, Hollings Cancer Center;Department of Pathology and Laboratory Medicine, Medical University of SouthCarolina, Charleston, SC 29425, USA.DOI: 10.18632/oncoscience.414 PMCID: PMC6049315PMID: 30035158 